Page last updated: 2024-09-05

sb 203580 and Diastolic Heart Failure

sb 203580 has been researched along with Diastolic Heart Failure in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berzingi, C; Chen, F; Finkel, MS	1

Other Studies

1 other study(ies) available for sb 203580 and Diastolic Heart Failure

Article	Year
p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivo. Cardiovascular toxicology, 2009, Volume: 9, Issue:3 Topics: Animals; Cardiomyopathies; Dose-Response Relationship, Drug; Heart Failure, Diastolic; HIV Envelope Protein gp120; Imidazoles; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley	2009

Article

Year

p38 MAP kinase inhibitor prevents diastolic dysfunction in rats following HIV gp120 injection in vivo.

Cardiovascular toxicology, 2009, Volume: 9, Issue:3

Topics: Animals; Cardiomyopathies; Dose-Response Relationship, Drug; Heart Failure, Diastolic; HIV Envelope Protein gp120; Imidazoles; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley

2009